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Abstract: 
Background: Selecting the best medication for upper GI endoscopy in children 
is a challenging issue. The goal of this study was to compare the effects of oral 
and intravenous midazolam for upper gastrointestinal endoscopy (UGIE) on 
children. 
Methods: In this randomized clinical trial study conducted in Amirkola 
Children's Hospital, 110 children were randomly assigned to oral or 
intravenous groups. An expert nurse recorded O2 saturation, heart rate before, 
during and 5 minutes after endoscopy for all patients. Sedation, separation 
from parents and child cooperation were recorded. 
Results: Heart rate before and during endoscopy was not significantly different 
between two groups while heart rate was significantly lower in IV group after 
endoscopy. Cooperation during bite block was significantly better in oral 
group. Cooperation during endoscopy was not significantly different between 
two groups. Separation from parents in both male and female ones was 
significantly better in oral group. Complications were reported in 7 cases in 
oral group and 6 in IV group. 
Conclusion: Oral midazolam in comparison with IV midazolam is better and 
may be a method of choice for pediatric UGIE purposes. 
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Introduction: 
The number of endoscopic procedures in children for diagnostic and 
therapeutic purposes is increasing in worldwide 
[1]
. As this method is invasive, 
discomfort during the procedure is common, which makes it difficult for both 
the physician and the patient. In children, the proper sedation is challenging as 
inappropriate sedation will cause longer duration and increase risk of 
complications as the result of less cooperation 
[2]
. To maximize cooperation, 
proper sedative agents to preserve consciousness are recommended 
[3]
. There is 
controversy regarding to select the best sedative agent. Any agent with rapid 
onset of action, minimal side effects and rapid recovery are optimal. 
Midazolam is a benzodiazepine with rapid onset of action. It acts by GABA 
(Gamma Amino Butyric Acid) accumulation and occupation of benzodiazepine 
receptors 
[4]
. It is used orally or intravenously in children settings for sedative 
purposes. The goal of this study was to compare the effects of oral and 
intravenous midazolam for upper gastrointestinal endoscopy (UGIE) in 
children. 
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Methods: 
In this randomized clinical trial study conducted in 
Amirkola Children's Hospital (affiliated hospital of 
Babol university), 120 children with 6 months to 12 
years old age were enrolled in 2014. 
Inclusion criteria: 
Patients with need for UGIE, class I or II ASA 
(American Society of Anesthesiologists) were selected. 
[5] 
Exclusion criteria: 
Patients with ASA class III or IV, pulmonary, 
cardiac, renal, psychological/mental disorders or 
infectious diseases, metabolic disorders, liver diseases, 
seizure history, previous endoscopy, hematologic 
diseases and fever, medical history including anti-
epileptic drugs, narcotics and anti-arrhythmic agents 
were excluded. 
All parents were asked to fill informed consent 
forms and the study had been approved by local ethics 
committee. All patients were NPO for 4-6 hours before 
UGIE. By means of computerized simple 
randomization, patients were randomly assigned to oral 
or intravenous midazolam group. 0.5 mg/kg oral 
midazolam with maximum dose of 20 mg was 
administered to oral group 20-30 minutes before 
endoscopy.  
Oral midazolam prepared as solution (5mg/mL) 
from injectable midazolam (Dormicum, Roche) and 2 
cc Dextrose Water 5%. 
For intravenous (IV) group, 0.15 mg/kg intravenous 
midazolam (Dormicum, Roche) was administered 3-5 
minutes before UGIE. An expert nurse recorded O2 
saturation, heart rate before, during and 5 minutes after 
endoscopy for all patients. All endoscopies were 
performed using Pentax Gasrodeodenoscope (E110236 
JAPAN).  
Separation from parents and child cooperation were 
recorded. Separation from parents was scored as 
follow: 1; quiet, 2; restless 
Child cooperation during bite block was scored as: 
Good: no movement during UGIE 
Moderate: movement control by another person 
Poor: movement control by more than one person 
Modified Ramsay sedation scoring was used to 
evaluate sedation. It is 1 to 6 point scales based on the 
level of the patient’s cooperation and response [6].  
Ramsey: 
1: Anxious, agitated, restless 
2: Cooperative, oriented, tranquil 
3: Responsive to commands only 
4: Brisk response to light glabellar tap or loud auditory 
stimulus 
5: Sluggish response to light glabellar tap or loud 
auditory stimulus 
6: No response to light glabellar tap or loud auditory 
stimulus 
All cases were under observation for three hours 
after endoscopy to detect complications. All data were 
analyzed using SPSS version 20 (SPSS Inc., Chicago, 
IL, USA). Continuous variables were compared using 
the Student-t test and categorical variables were 
compared using the x2 test. P value less than 0.05 was 
considered significant. 
 
 
Results: 
One hundred and twenty children were enrolled. 
Five patients in each group were withdrawn from the 
study.  
Table 1 shows demographic characteristics of 
patients. Heart rate before and during endoscopy was 
not significantly different between two groups while 
heart rate was significantly lower in IV group after 
endoscopy (table 2). 
Separation from parents was more easily in oral 
group (table 3). Cooperation during bite block was 
significantly better in oral group (table 4).  
Cooperation during endoscopy was not 
significantly different between two groups (table 5).  
Separation from parents in both male and female 
ones was significantly better in oral group (table 6). 
Complications were reported in 7 cases in oral group 
and 6 in IV group (p=0.2). 
In oral group, the complications were as follow: 3 
(5.4%) transient diplopia, 2 (3.6%) vomiting and 2 
(3.6%) hiccough and complications in IV group were 
as follow: 3 (5.4%) vertigo, 1 (1.8%) vomiting, 2 
(5.4%) agitation. 
In oral group, Ramsey score in 41 (74.5%) was 1 
and in 14 (25.4%) was 2 while in IV group, Ramsey 
score were 1, 2 and 4 in 34 (61.8%), 20 (36.3%) and 1 
(1.8%), respectively (table 7).  
 
 
Table 1: Demographic characteristics of patients 
 Oral Intravenous P value 
Age (year) 4.5±2.5 4.6±3.2 0.6 
Sex 
Male 
Female 
33(58.2%) 
23(41.8%) 
27(49.1%) 
28(50.9%) 
0.08 
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Table 2: Heart rate and O2 saturation before (B), 
during (D) and after (A) endoscopy (E). 
 Oral Intravenous 
P 
value 
Heart rate BE 117.9±14.3 114.4±18.2 0.09 
O2 saturation 
BE (%) 
97.1±1.1 96.9±1.1 0.4 
Heart rate DE 148.5±18.7 150.8±19.4 0.5 
O2 saturation 
DE (%) 
90.8±4.4 89.6±4.4 0.1 
Heart rate AE 143±19 132±19.9 0.005 
O2 saturation 
AE(%) 
97.03±1.3 97.3±0.9 0.1 
 
 
Table 3: Separation from parents before UGIE 
 
Oral 
N(%) 
Intravenous 
N(%) 
P 
value 
Quiet 47(85.4) 29(52.7) 
<0.001 
Restlessness 
Mild 3(5.5) 16(29.1) 
Moderate 2(2.6) 7(12.7) 
Severe 3(5.5) 3(5.5) 
 
 
Table 4: Cooperation during bite block 
 
Oral 
N(%) 
Intravenous 
N(%) 
P value 
Good 39(70.9) 27(49.1) 
0.02 Moderate 14(25.5) 26(47.3) 
Poor 2(3.6) 2(3.6) 
 
 
Table 5: Cooperation during endoscopy 
 
Oral 
N(%) 
Intravenous 
N(%) 
P value 
Good 11(20) 7(12.7) 
0.1 Moderate 39(70.9) 39(70.9) 
Poor 5(9.1) 9(16.4) 
 
 
Table 6: Separation from parents  
  
Oral 
N(%) 
Intravenous 
N(%) 
P value 
Male 
Quiet 
Restless 
28(87.5) 
4(12.5) 
16(56.3) 
11(40.7) 
0.04 
Female 
Quiet 
Restless 
19(82.6) 
4(17.4) 
13(46.4) 
15(53.6) 
0.03 
 
 
 
Table 7: Ramsey score in two groups: 
Score 
Oral 
N(%) 
Intravenous 
N(%) 
P value 
Score 1 41 (74.5) 34 (61.8) 
0.14 
Score 2 14 (25.4) 20(36.3) 
Score 3 0 0 
Score 4 0 1(1.8) 
Score 5 0 0 
Score 6 0 0 
 
 
Discussion: 
The result of current study showed that oral 
midazolam is as effective as IV midazolam for sedation 
before UGIE in children and oral midazolam was 
superior medication in separating children from their 
parents. As the number of endoscopic procedures 
increases for pediatrics, the need for proper sedations 
increases, too. These procedures could be done in 
operating rooms or endoscopy rooms 
[7]
. Nevertheless, 
the best sedation protocol has not been established up 
to now 
[1]
. Due to different strategies and protocols in 
different hospitals, different medications are used for 
this purpose 
[8]
. 
Different sedative agents have been used for 
sedation such as Benzodiazepines (eg, midazolam, 
lorazepam, diazepam), opioids (eg, morphine, fentanyl, 
meperidine), and sedative-hypnotics (eg, chloral 
hydrate, ketamine). Inhaled agents (sevoflurane and 
nitrous oxide) and IV propofol also have been used 
 
[9-11]
. In most pediatric units, IV midazolam is a 
sedative choice. Midazolam is a short-acting 
benzodiazepine, which acts during 5 minutes and 
reaches to peak effect within 3-5 minutes 
[12]
. It is used 
as anxiolytic, muscle relaxant, and anticonvulsant 
agent 
[13]
. It applies most of its effects by interacting 
with inhibitory neurotransmitter receptors as GABA 
receptors 
[14]
.  
In the present study, we compared oral and IV 
midazolam for sedation before UGIE. The results 
showed that heart rate after endoscopy was 
significantly lower in IV group while separation from 
parents was easier in oral group. Lamireau et al.’s 
found that heart rate and blood pressure increase during 
endoscopy with IV midazolam sedation in comparison 
with general anesthesia 
[15]
. Ramsey score one was 
more reported in oral group than intravenous group 
while there was no statistically significant difference 
between Ramsey scores of two groups. 
The results of current study also showed that 
cooperation during bite block was significantly better 
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in oral group than IV group. Separation from parents in 
both males and females was significantly better in oral 
group than IV group. Feld et al.’s reported that ease of 
separation from parents is associated with the use of 
oral midazolam 
[16]
. In a previous study, Kaviani et al.’s 
suggested that separation from parents was 
significantly better in oral midazolam group than 
control group in children who were referred to dentist 
[17]
. In another study, Rafeey et al.’s evaluated 30 
children in oral midazolam group and 31 in IV 
midazolam group who underwent upper GI endoscopy 
[18]
. They investigated that ease of separation from 
parents, ease of ability to monitor the patient during the 
procedure, heart rate, systolic arterial pressure, or 
respiratory rate were not significantly different between 
two groups. However, oxygen saturation was 
significantly lower in the IV group than the oral group 
while in this study, oxygen saturation in different time 
was similar in both groups. 
In the current study, the rate of complications was 
not significantly different between two groups while 
diplopia was the most common complication in oral 
group and vertigo was the most complication in IV 
group. In the study of Oh et al.’s the nausea was the 
most common complication in IV midazolam group 
while in Hulland's study, vomiting was the most 
common complication in oral midazolam group 
[1, 19]
.  
Oral midazolam in comparison with IV midazolam 
is better choice for pediatric UGIE purposes. 
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